Citadel Advisors
HQCL

Citadel Advisors’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Citadel Advisors’s Portfolio HQCL Stock Details HQCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,400
Closed -$102K – 10185
2018
Q3 		$102K Buy
+12,400
New +$93.2K ﹤0.01% 8575

Other funds holding HQCL

MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CMG
Cavalry Management Group San Francisco, California $22.3M AUM 65.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Citadel Advisors's HQCL Position: Q4 2018 in Review

Citadel Advisors sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q4 2018, closing a stake of 20,530 shares — an estimated $169K sold.

Citadel Advisors first reported a position in HQCL in Q2 2013 and held it in 9 quarters. The position peaked at $3.5M in Q3 2013. 18 funds tracked by Wall St. Rank hold HQCL as of Q4 2018.

  • Citadel Advisors reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q4 2018 after selling out during the quarter.
  • Citadel Advisors sold 20,530 Hanwha Q CELLS Co., Ltd. shares in Q4 2018, an estimated $169K.
  • Citadel Advisors first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and held it in 9 quarters.
  • Citadel Advisors's Hanwha Q CELLS Co., Ltd. position peaked at $3.5M in Q3 2013.
  • 18 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q4 2018.

Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.